|
1 Event Eli Lilly Investors Must Watch
|
1
|
Mannkind
|
Feb 15, 2013 10:19PM
|
|
1 Deadly Disease Getting Plenty of Attention
|
1
|
Mannkind
|
Oct 04, 2012 10:54AM
|
|
1 Catalyst Biotech Investors Need to Watch
|
1
|
Mannkind
|
Dec 13, 2012 04:05PM
|
|
$8.25
|
5
|
Mannkind
|
Aug 01, 2013 01:17PM
|
|
$33,000 Portfolio: Mostly Cash Ahead Of Elections And Snow-Hurricanes
|
|
Mannkind
|
Oct 30, 2012 02:53PM
|
|
$33,000 American Portfolio: Closing A Position And Moving Into Bio And Pharma
|
|
Mannkind
|
Jul 23, 2012 12:03PM
|
|
MNKD Summer Street says 'suspicious' of MannKind AFFINITY trial
|
|
Mannkind
|
Aug 16, 2013 10:20AM
|
|
MannKind: Managing The Endgame
|
2
|
Mannkind
|
Aug 07, 2013 10:58AM
|
|
Biotech: Let's Make A Billion-Dollar Deal
|
|
Mannkind
|
Jul 17, 2013 12:09PM
|
|
10 Most-Shorted Biotech Stocks of 2013
|
|
Mannkind
|
Jun 20, 2013 07:25PM
|
|
*** Mannkind Assigned Patent ALEXANDRIA, Va., July 29
|
1
|
Mannkind
|
Jul 29, 2013 09:50PM
|
|
MannKind gaps up, resistance now at $3.30
|
|
Mannkind
|
Jul 16, 2012 10:52AM
|
|
Seeking Alpha
|
1
|
Mannkind
|
Jul 06, 2012 08:50AM
|
|
MannKind Nears End of Clinical Trial, Medical Breakthrough
|
2
|
Mannkind
|
Jul 23, 2013 04:08PM
|
